If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

Share Price is delayed by 15 minutes
Get Live Data
1.75    0.00 (0.00%)
Bid:
1.485
Ask:
1.75
Spread: 0.265 (17.845%)
Market Cap: £1.80m
LIT Live PriceLast checked at - London Stock Exchange

Intraday Litigation Cap. Share Chart

Market Update

19 Jul 2021 07:00

RNS Number : 6352F
Litigation Capital Management Ltd
19 July 2021
 

19 July 2021

 

Litigation Capital Management Limited

("LCM" or "the Company")

 

Market Update

 

 

Litigation Capital Management Limited (AIM:LIT), a leading international alternate asset manager of disputes financing solutions, is pleased to provide a market update for the year ended 30 June 2021 (FY21).

 

 

·

LCM's 10 year track record remains robust with 10 year portfolio ROIC as at 30 June 2021 of 153% and cumulative portfolio IRR of 78%

·

The Global Alternative Returns Fund (GAR) is currently 76% committed achieved in 15 months, versus an investment target period of 24 months. Overall capital commitment of US$115m of US$150m. The second fund is progressing well with a close targeted for Q3 of this calendar year

·

Applications increased 10%, with 572 applications received during FY21

·

Conversion into active investments was also consistent at 3%, with an increase in high profile quality investments requiring increased resource allocation. This conversion rate demonstrates LCM's discipline and consistency in applying its rigorous due diligence in investment selection

·

Whilst all other scale metrics showed an increase on the year prior, the level of commitments was down due to our due diligence and investment selection taking longer due to COVID. This increased due diligence time recognises a general slow-down in all sectors of legal services consequent upon COVID

·

Total portfolio capital commitment of $181m comprises $105m of Direct investments alongside a further $76m of Fund co-investment maintaining a diverse portfolio of investments

 

Patrick Moloney, CEO of LCM, commented: "LCM and our team have performed very well in what has been a tough and disrupted year. The GAR Fund is now over 75% committed, and we are making significant progress on the second fund with strong support from both existing and new investors. Notwithstanding some disruption to global justice systems, LCM's portfolio of disputes continues to mature.

"We are pleased to have achieved a significant resolution of an investment close to the end of the financial year which has generated strong revenue and exceptional performance metrics.

"We look forward to the coming year with optimism and an expectation that global economic conditions will be very conducive to growth.

 

Direct Investment

LCM's direct investments fall into two categories:

· Direct Balance sheet investments 100% funded by LCM; and

· Co-Investment funding alongside the Fund

LCM manages a direct investments portfolio with a capital commitment of $105m, which now comprises 30 separate investments including 8 investments in our acquisition strategy. Our Corporate Portfolios continue to achieve resolutions with consistent metrics.

Our portfolio of direct investments is progressing as anticipated, with our most recently announced resolution achieving an IRR of 121% and a ROIC of 313%.

Asset Management  

LCM has now committed 76% of the US$150m Fund across 22 projects while maintaining diversity across commercial litigation, insolvency disputes, class actions and arbitration.

All investors in Fund I have expressed a strong interest to participate in Fund II which is targeted at a size of US$300m. This demonstrates the strength of the relationships developed since launching Fund I in March 2020.

Application conversions were marginally lower at 3% as the restrictions imposed in response to the COVID pandemic continued across the globe. This expected lowering in conversion reflects LCM's rigorous due diligence adapting to market conditions particularly in the area of recovery. Despite the challenges faced and the limited client interaction, LCM added a number of high quality and high profile investments to its portfolio during the period. Notwithstanding these challenges, LCM maintained its rigorous investment selection process, ensuring the future performance of our portfolio is preserved and delivers in line with our track record.

 

Strategic Alliances

LCM's Strategic Alliances continue to generate applications and, as restrictions in the UK start to lift, we expect to see this increase as we resume business meetings and develop the investment selection process with the teams we work with.

The accompanying market update presentation is available on LCM's website:

https://www.lcmfinance.com/shareholders/investor-presentations-results/

 

 

Enquiries

 

Litigation Capital Management

c/o Alma PR 

Patrick Moloney, Chief Executive Officer

 

 

 

 

 

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam

 

 

 

 

 

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

 

 

 

 

 

Alma PR

Tel: 020 3405 0205

Justine James

Susie Hudson

Kieran Breheny

Molly Gretton

LCM@almapr.co.uk

 

 

 

 

NOTES TO EDITORS

 

Litigation Capital Management (LCM) is a global provider of disputes finance. LCM provides capital and risk manager services into the disputes market including insolvency, commercial disputes, arbitral disputes, class actions and corporate portfolios. LCM operates two distinct business models: direct balance sheet investments and asset management. Under those business models, LCM pursues three investment strategies: single-case funding, corporate portfolio funding and the acquisition of claims.

LCM has an unparalleled track record, driven by effective project selection, active project management and robust risk management.

 

Current headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFFSIUEFSEIW
Date   Source Headline
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
23rd Nov 20234:51 pmRNSDirector/PDMR Shareholding
31st Oct 20233:53 pmRNSExercise of Awards
17th Oct 20231:00 pmRNSResult of AGM
10th Oct 20237:00 amRNSTransaction in Own Shares
9th Oct 20237:00 amRNSTransaction in Own Shares
5th Oct 20231:40 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSShare Buyback Programme
2nd Oct 20237:00 amRNSDividend currency entitlement
19th Sep 20237:00 amRNSFinal Results
13th Sep 20231:00 pmRNSLondon Investor Event
12th Sep 20234:17 pmRNSNotice of AGM - Correction
12th Sep 20237:00 amRNSNotice of AGM
4th Sep 20237:00 amRNSSettlement in Australian class action
30th Aug 20237:00 amRNSNotice of Results
27th Jul 20237:00 amRNSUpdate following Supreme Court ruling
20th Jul 20237:00 amRNSProgress on Fund I investment
18th Jul 20237:00 amRNSFair Value Accounting and Dividend Payment
22nd Jun 20237:00 amRNSSuccessful resolution of balance sheet investment
19th Jun 20237:00 amRNSResolution of Investment
15th May 20239:48 amRNSSettlement in Australian class action
3rd Apr 20237:00 amRNSResolution of investment
20th Mar 20237:00 amRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSHalf-year Report
9th Mar 20237:00 amRNSSettlement in Australian class action
27th Feb 20239:30 amRNSNotice of Results
23rd Feb 20237:00 amRNSProgress on direct balance sheet investment
20th Feb 20237:00 amRNSSuccessful settlement in the Carillion claim
20th Dec 20227:00 amRNSProgress on portfolio of Investments
29th Nov 20227:00 amRNSDirector/PDMR Shareholding
16th Nov 20227:04 amRNSResult of AGM
20th Oct 20227:00 amRNSNew Litigation Finance Agreement
19th Oct 20229:26 amRNSNotice of AGM
13th Oct 20223:44 pmRNSIncentive Awards
4th Oct 20227:00 amRNSSecond close of Global Alternative Returns Fund II
29th Sep 20229:30 amRNSDirector/PDMR Shareholding
26th Sep 20226:00 pmRNSDirector/PDMR Shareholding
20th Sep 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.